Torrent Pharmaceuticals Limited has informed the Exchange about Presentation to analysts on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2022

21st October, 2022

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager – Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Presentation to analysts on unaudited Consolidated Financial Results for the quarter

and half year ended 30th September, 2022

The Presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2022 to be made to analysts is enclosed for your records.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN M. TRIVEDI COMPANY SECRETARY

Encl : A/a

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com

Q2 FY 2022-23

Revenues: Summary

1

Revenue: Summary

Revenues (Rs cr)

Q2 FY23

Q2 FY22

Gr%

India

United States

Germany

Brazil

Other countries

Others

Total

1,224

1,087

292

220

185

239

131

284

251

156

219

140

2,291

2,137

13%

3%

-12%

19%

10%

-7%

7%

2